BioMed Central in China

News in China

BioMed Central Open Access Day
A Most Successful Day

BioMed Central Open Access Day was successfully held in Shanghai, October 21. Over 80 professors and senior researchers from Shanghai, Hangzhou, Nanjing, Suzhou, and Wuxi participated in the event. As part of OA Week activities in China, BioMed Central Open Access Day perfectly achieved its mission of “Boost Research Excellence, Promote Academic Success”. Meanwhile, BioMed Central Open Access Day also built an open platform for researchers and editors, where they can realize face-to-face communication and facilitate the publication of research output from China. Participants of BioMed Central Open Access Day spoke highly of the event and hoped that BioMed Central could organize more Open Access theme events in the future. BioMed Central Open Access Day was reported by China state news agency XinhuaNet and the largest science community ScienceNet.

Fudan University joined BioMed Central Membership Program

Fudan University, one of the best universities in China, joined BioMed Central Membership Program to show their support for open access publishing. Founded in the year of 1905, Fudan has been one of the most prestigious names in China for over a century and continues to be a top university today. As the university that published most in BioMed Central journals over the last three years, Fudan will benefit greatly from the membership program.

Ming K. Jeang Award for Excellence in Cell & Bioscience

Cell & Bioscience announces the establishment of the Ming K. Jeang Award for Excellence in Cell & Bioscience. The Award, consisting of $500 cash and a certificate, is funded by a generous donation from the Ming K. Jeang Foundation and intends to honor outstanding research papers published in Cell & Bioscience. Three research groups led by Dr. Lixin Feng of Shanghai JiaoTong University School of Medicine, Shanghai, China (Full Text), Dr. Walter Wahli of University of Lausanne, Lausanne, Switzerland (Full Text) and Dr. Gutian Xiao of University of Pittsburgh Cancer Institute, Pittsburgh, USA (Full Text), won the 2012 Ming K Jeang Award for Excellence in Cell & Bioscience. See more details here.

Infectious Diseases of Poverty aims for One Health, One world

BioMed Central, in partnership with the National Institute of Parasitic Diseases, China CDC (NIPD), has launched a new open access journal, Infectious Diseases of Poverty. The official launch coincides with the Second Global Symposium on Health Systems Research held in Beijing China. The inaugural issue focuses on the health system research for controlling infectious diseases of poverty, discussing treatment strategies and innovative programmes which provide a link between policy level and academic research.

Journal of Animal Science and Biotechnology and Translational Neurodegeneration were tracked by PubMed in the first year of their launch

Two BioMed Central journals, in partnership with Chinese institutes, were tracked by PubMed in the first year of their launch. Journal of Animal Science and Biotechnology is co-pulishing with College of Animal Science and Technology, China Agricultural University Translational Neurodegeneration, a co-publishing journal between BioMed Central and Department of Neurology, Ruijin Hospital. Their content will be searched in PubMed and full-text will be freely available in PubMed Central.

Cell Regeneration welcomes your best research

Cell Regeneration has published its first set of high quality research articles with BioMed Central. It welcomes novel research articles as well as in depth reviews in modern biology, especially in the field of stem cell and regenerative biology, and regenerative medicine. The journal is supported by Guangzhou Institute of Biomedicine and Health, which covers APCs for all authors. In the launch issue it presented novel approaches to grow cells in vitro or ideas that may eventually help us to regenerate cell or tissues in vivo.


Search BioMed Central

Search topics

Email updates

Receive periodic news and updates relating to BioMed Central.